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Abstract Medical avoidance is common among U.S.
adults, and may be emphasized among members of marginalized communities due to discrimination concerns. In
the current study, we investigated whether this disparity in
avoidance was maintained or exacerbated during the onset
of the COVID-19 pandemic. We assessed the likelihood of
avoiding medical care due to general-, discrimination-, and
COVID-19-related concerns in an online sample (N = 471).
As hypothesized, marginalized groups (i.e., non-White
race, Latinx/e ethnicity, non-heterosexual sexual orientation, high BMI) endorsed more general- and discrimination-related medical avoidance than majoritized groups.
However, marginalized groups were equally likely to seek
COVID-19 treatment as majoritized groups. Implications
Supplementary Information The online version contains
supplementary material available at https://doi.org/10.1007/
s10865-022-00332-3.

for reducing medical avoidance among marginalized groups
are discussed.
Keywords Medical avoidance · Discrimination · COVID19 · Race/ethnicity · Sexual orientation · BMI
The novel coronavirus (COVID-19), first detected in December 2019, progressed to the level of a global pandemic in
a matter of months (Cucinotta & Vanelli, 2020). COVID19 is unique from many common illnesses in that it is a
highly infectious respiratory virus and contraction is not
linked to any particularly stigmatized behavior (e.g., risky
sexual behavior, substance use, or a high-caloric diet). After
the initial case of COVID-19 was identified in the United
States in March 2020, the virus spread rapidly to all 50
states, reaching 44,615,528 confirmed cases and resulting
in over 718,000 deaths by October 2021 (Centers for Disease
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Control and Prevention, 2022). Americans were faced with
images of overrun hospitals, hospital wards dedicated to
ventilating patients, and freezer trucks storing an overflow of
bodies (Miller, 2020). These images, and subsequent reporting on the COVID-19 virus, sent frightening messages to the
public about the seriousness of a COVID-19 infection and
the potential necessity of medical treatment (Miller, 2020).
The threat of COVID-19 and the medical attention it often
necessitated was particularly salient for members of marginalized groups (e.g., non-White race, Latinx/e ethnicity,
high BMI) who were more likely to have severe cases of
COVID potentially resulting in serious illness or death, and
have historically been more likely to avoid medical treatment (Alcendor, 2020; Muñoz-Price et al., 2020; Shah et al.,
2020).
Prior to the COVID-19 pandemic, marginalized populations historically avoided medical treatment at higher rates
than majority populations (Clancy, 2011; Interian et al.,
2013). For example, disparities have existed in preventative screening, with minoritized groups being less likely to
engage in this type of care than their majoritized counterparts (Berry et al., 2009; Japuntich et al., 2018; Pope et al.,
2021; Price et al., 2020). Recent research investigating the
impacts of the COVID-19 pandemic on medical care avoidance among marginalized and majority groups has indicated
that the disparity in medical care avoidance could be growing. Specifically, emergency department (ED) visits during the early part of the pandemic decreased significantly
across all racial groups, insurance types, and acuteness of
conditions (Misa et al., 2021; Yu et al., 2021). Importantly,
Black and Hispanic adults were more likely to avoid seeking emergency healthcare during the pandemic than White
adults (Czeisler et al., 2020). Persons with disabilities,
underlying medical conditions, and unpaid caregivers were
also more likely to avoid seeking both routine and emergency care (Czeisler et al., 2020). Life-saving, preventative
screenings, such as mammograms, pap smears, and testicular
cancer checks, have also significantly declined during the
pandemic among the wider population (Cancino et al., 2020;
Del Vecchio Blanco et al., 2020; Gupta & Lieberman, 2020;
Hoehn & Zureikat, 2020; Wright et al., 2020). As services
resume, recent work has documented Black and Latinx/e
communities may be more reluctant to engage with this type
of care during the COVID-19 pandemic than White adults
(Carethers et al., 2020).
Prior experiences with inadequate care due to discrimination—by both individual healthcare providers and the
healthcare system—contribute to higher medical avoidance among marginalized populations (Jaiswal & Halkitis, 2019; McGuigan & Wilkinson, 2015; Pellowski et al.,
2017; Underhill et al., 2015). Experiences with systemic discrimination and individual provider bias also contribute to
adverse health outcomes within these communities (Abdou

761

& Fingerhut, 2014; Reader & Gillespie, 2013). For example, many healthcare providers endorse stereotypes regarding larger-bodied people (e.g., they are lazy, unintelligent,
and/or non-compliant; Blumberg & Mellis, 1985; Greenleaf
et al., 2006; Phelan et al., 2014) that can negatively impact
the quality of care they provide for their patients (Phelan
et al., 2014). Other marginalized communities have similar
experiences and, as a result, mistrust medical professionals
and avoid seeking care.
There is little information about how avoidance of medical care in general (i.e., avoidance of care despite suspected
need of care), or avoidance of medical care due to discrimination-related concerns (i.e., avoidance of care related to
receiving differential, poorer treatment based on one’s identity) or COVID-19 concerns, may differ for marginalized
groups. It may be the case that members of marginalized
groups avoid medical care for COVID-19 at similar rates
as they would avoid medical treatment in general. Alternatively, due to the heightened risk of severe COVID-19
outcomes, marginalized groups may be less likely to avoid
medical care for COVID-19 than for general medical treatment. In line with past research, we expect that marginalized
groups will report more medical care avoidance in general,
and more avoidance due to discrimination concerns. Furthermore, mirroring patterns of preventative care, we expect
more COVID-19 care avoidance by marginalized groups
than majoritized groups.

Method
Participants
Participants were 621 adults living in the U.S. who consented to take part in a study on “health behavior in the
time of COVID-19.” Of those, 471 completed at least one of
the variables of interest in the present study (MAge = 26.33,
SDAge = 8.46; MBMI = 27.19; SDBMI = 6.74). Further participant details can be found in Table 1. Degrees of freedom
vary due to missing data.
Procedure
Participants were recruited via social media posts advertising the study, and via an email list from prior studies conducted by the Hunter Alliance for Research and Translation
(HART) on sexual health, containing participants who had
consented to be contacted again for future research purposes.
Eligibility criteria were being 18 years or older, being fluent
in English, and living in the United States.
The survey was conducted fully online using the RedCap platform and was self-paced. Participants could skip
any items they did not wish to answer, which is reflected in
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Table 1  Demographics
Characteristic
Gender
Men
Women
Non-binary
Agender
Don’t know
Other ID
Transgender
Cisgender
Sexual orientation
Heterosexual
Gay or Lesbian
Bisexual
Queer
Pansexual
Asexual
Not Sure
Other ID
Race
White
Black/African American
East Asian
West Asian
Native American/Alaska Native
Multiracial
Other ID
Ethnicity
Hispanic/Latino/x
Not Hispanic/Latino/x
Income
< $10,000
$10,000–$20,000
$20,000–$55,000
$55,000–$75,000
$75,000–$100,000
$100,000–$250,000
$250,000 +
Education
Some highschool
Highschool/Equivalent
Some college
College
Some post-graduate
Master’s degree
Doctorate degree
Other

% (N)
45.4 (233)
27.3 (140)
7.4 (38)
0.4 (2)
0.8 (4)
0.2 (1)
8.4 (43)
71.5 (367)
34.9 (179)
15 (77)
13.1 (67)
8.6 (44)
4.9 (25)
2.3 (12)
2.3 (12)
1.6 (8)
55.8 (286)
6.4 (33)
3.3 (17)
0.8 (4)
0.4 (2)
9.6 (49)
4.5 (23)
16 (82)
62.4 (320)
1.2 (6)
6 (31)
13.5 (69)
8.8 (45)
10.1 (52)
12.3 (63)
2.9 (15)
1.1 (8)
5.5 (41)
16.5 (123)
17.5 (130)
5 (37)
12.4 (92)
3.6 (27)
0.7 (5)

Characteristic

M (SD)

Age
BMI

26.33 (8.46)
27.19 (6.74)
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fluctuating degrees of freedom in the analyses. Compensation was given in the form of 17 raffled virtual gift cards for
$40 USD. Data collection occurred from April 2020-June
2020. For context, COVID-19 was declared a global pandemic in March 2020 and quarantine restrictions were in
place throughout the U.S. and internationally during the data
collection period (Cucinotta & Vanelli, 2020).
Measures
These data were taken from a larger survey on multi-faceted
health outcomes during the COVID-19 pandemic in the
United States. The purpose of the larger study was to examine individuals’ risk perception and prevention behaviors,
sexual health and healthcare access, and mental health during the COVID-19 pandemic. Here we only include measures relevant to the current study.
Demographics
Participants reported their gender, age, sexual orientation,
race or ethnicity, height, weight, income, and education level
(see Table 1). Bivariate correlations of all variables included
in the analysis are presented in Supplemental Table 1.
Medical avoidance and trust items
Included in the survey were several measures of medical
avoidance, drawn largely from the HINTS 2005 survey
(National Cancer Institute, 2005). The COVID-related
avoidance item was created by the research team to address
the concept of COVID-care avoidance, not covered by the
HINTS items. All items were measured with Likert-type
scales and coded or re-coded such that higher values indicated greater avoidance. Table 2 presents the descriptive
statistics of the following items:
Medical avoidance in general “Some people avoid visiting their doctor even when they suspect they should go
get checked out. How true would you say this is for you?”
(1 = not true at all; 5 = completely true).
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Discrimination‑related avoidance “I avoid seeing my
doctor because I worry that I will be discriminated against
in the healthcare setting” (1 = strongly agree; 4 = strongly
disagree; reverse coded prior to analysis).
COVID‑related avoidance “If I was infected with COVID19, I would wait until ‘the last second’ to go to the hospital if my symptoms became serious” (1 = highly unlikely;
7 = highly likely).
Data analysis plan
We conducted bivariate correlations and independent samples t-tests to determine associations between the stigmatized identities of interest (race, ethnicity, sexual orientation, BMI) and each type of medical avoidance (general,
discrimination, COVID-19). We conducted twelve separate
linear regression models to determine whether marginalized
status in each group predicted each type of avoidance (e.g.,
Model 1 tested marginalized race on general medical avoidance, Model 2 tested marginalized race on discriminationrelated avoidance, etc.). Our predictor variables included
race (0 = White, 1 = non-White), ethnicity (non-Latinx = 1,
Latinx = 2), sexual orientation (0 = heterosexual, 1 = nonheterosexual), and BMI. Age, education, income, and gender
(0 = man; 1 = any other gender identity) were included as
covariates in each of the regressions.

Results
On average, participants endorsed moderate general avoidance (M = 2.61, SD = 1.34), mild discrimination-related
avoidance (M = 1.77, SD = 1.04), and moderate COVID19-related avoidance (M = 3.74, SD = 2.13). Without controlling for covariates, all three types of medical avoidance
were significantly associated with stigmatized identities
when computing independent samples t-tests, albeit inconsistently across groups. Race and sexual orientation were
both associated with discrimination avoidance. Participants
who did not identify as White, t(458) = − 2.869, p = 0.004,
and participants who did not identify as heterosexual,

Table 2  Medical Avoidance Items
Item

Mean (SD)

Some people avoid visiting their doctor even when they suspect they
should go get checked out. How true would you say this is for you?
I avoid seeing the doctor because I worry that I will be discriminated
against in the healthcare setting
If I was infected with COVID-19, I would wait until "the last second"
to go to the hospital if my symptoms became serious

2.60 (1.36)
1.77 (1.02)
3.72 (2.13)
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no significant differences in COVID avoidance between
Latinx/e (M = 2.16, SD = 0.22) and non-Latinx/e (M = 2.14,
SD = 0.11) participants, 𝛽 = − 0.04, p = 0.401. Results are
presented in Table 4.

t(456.6) = − 8.025, p < 0.001, reported higher discrimination-based medical avoidance. Race and sexual orientation
were unrelated to general medical avoidance and COVID-19
medical avoidance in bivariate correlations. There were no
differences between Latinx/e and non-Latinx/e participants
on any of the avoidance measures. Participants with higher
BMIs reported greater general medical avoidance, r = 0.12,
p = 0.033, and greater discrimination avoidance, r = 0.24,
p < 0.001, but BMI was not significantly related to COVID19 medical avoidance.

Sexual orientation
There were no significant differences between heterosexual (M = 2.68, SD = 1.29) and non-heterosexual (M = 2.54,
SD = 1.38) participants’ general avoidance of medical care, 𝛽
= − 0.06, p = 0.249. Non-heterosexual (M = 2.03, SD = 1.09)
individuals endorsed more discrimination avoidance than
heterosexual participants (M = 1.35, SD = 0.74), 𝛽 = 0.29,
p < 0.001. There were no significant differences in COVID
avoidance between heterosexual (M = 3.71, SD = 2.18) and
non-heterosexual (M = 3.73, SD = 2.11) participants,𝛽 =
− 0.04, p = 0.417. Results are presented in Table 5.

Race
Contrary to expectations, after controlling for age, education, income, and gender, non-White participants (M = 2.45,
SD = 1.30) reported significantly lower levels of general
medical avoidance than White participants (M = 2.66,
SD = 1.36), 𝛽 = − 0.113, p = 0.016. However, for discrimination medical avoidance, non-White participants (M = 1.98,
SD = 1.09) reported greater avoidance than did White
(M = 1.68, SD = 0.98) participants, 𝛽 = 0.099, p = 0.030.
There were no significant differences in COVID avoidance between non-White (M = 3.66, SD = 2.15) and White
(M = 3.77, SD = 2.13) participants, 𝛽 = − 0.059, p = 0.211.
Results are presented in Table 3.

BMI
BMI positively predicted general medical avoidance ( 𝛽 =
0.13, p = 0.024). As BMI increased, so did general medical
avoidance. Greater BMI was also associated with higher ratings of discrimination avoidance, 𝛽 = 0.23, p < 0.001. BMI
did not significantly predict COVID medical avoidance, 𝛽 =
0.05, p = 0.378. Results are presented in Table 6.

Ethnicity

Exploratory analyses

There were no significant differences in Latinx/e (M = 2.76,
SD = 1.41) and non-Latinx/e (M = 2.54, SD = 1.31) participants’ endorsement of general avoidance of medical
care, 𝛽 = 0.03, p = 0.574. Latinx/e participants (M = 1.83,
SD = 1.02) did not differ from non-Latinx/e (M = 1.75,
SD = 1.04) participants in their discrimination-based
avoidance,𝛽 = − 0.019, p = 0.684. Further, there were

Given our unexpected results showing that racial and sexual
minorities, as well as larger-bodied people, do not show any
differences in COVID-related avoidance from their majoritized counterparts, we were curious if these findings were
driven by reported avoidance among dominant or subjugated
groups. Put another way: are thinner individuals (for example) avoiding COVID-related care more compared to their

Table 3  Linear regression coefficients for the association between medical avoidance types and participant race
Model 1: General Avoidance
β

SE

Race
Covariates
Age
Education
Income
Gender

p

95% CI
LL

Model 2: Discrimination Avoidance
β

SE

UL

p

95% CI
LL

Model 3: COVID Avoidance

0.10 0.02

0.42

− 0.116 *
− 0.086
− 0.038
0.069 *

0.033
0.112
0.420
0.016

0.01
0.04
0.03
0.10

0.01
0.711
0.11
0.317
− 0.04 < 0.001
0.69
< 0.001

− 0.001
0.02
0.04
0.44

− 0.019
0.052
− 0.169 ***
0.243 ***

− 0.01
− 0.03
− 0.14
0.31

0.030

p

95% CI
LL

0.016 0.099 *

− 0.03
− 0.17
− 0.09
− 0.07

SE

UL

− 0.113 * 0.14 − 0.60 − 0.06
0.01
0.05
0.03
0.13

β

UL

− 0.059 0.22 − 0.70 0.16

0.211

0.011
− 0.011
0.038
0.168
**

0.842
0.842
0.424
0.001

0.01
0.08
0.05
0.21

− 0.02
− 0.17
− 0.06
0.31

0.03
0.14
0.15
10.13

Model 1: R2 = 0.05, adjusted R2 = 0.04, F(5, 442) = 4.30, p = 0.001; Model 2: R2 = 0.12, adjusted R2 = 0.11, F(5, 438) = 11.81, p < 0.001; Model
3: R2 = 0.03, adjusted R2 = 0.02, F(5, 439) = 2.73, p = 0.019; β Standardized regression coefficient, SE Standard error, CI Confidence interval,
LL Lower limit, UL Upper limit, p = p-value. *p < 0.05, ** p < 0.01, *** p ≤ 0.001
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Table 4  Linear regression coefficients for the association between medical avoidance types and participant ethnicity
Model 1: General Avoidance
β

SE

p

95% CI
LL

Ethnicity

Model 2: Discrimination Avoidance

0.027

0.16

β

SE

LL
0.39

0.574

− 0.019

p

95% CI

UL
− 0.22

Model 3: COVID Avoidance

0.12

β

SE

UL
− 0.28

0.18

p

95% CI
LL

0.684

− 0.041

0.25

− 0.70

UL
0.28

0.401

Covariates
Age

− 0.081

0.01

− 0.03

0.004

0.144

− 0.022

0.01

− 0.02 0.01

0.690

0.050

0.01

− 0.02

0.04

0.371

Education

− 0.112 * 0.05

− 0.20

− 0.002

0.045

0.046

0.04

− 0.04

0.10

0.396

− 0.042

0.08

− 0.22

0.10

0.450

Income

− 0.033

0.04

− 0.09

0.05

0.499

− 0.175
***

0.03

− 0.15

− 0.05

< 0.001

0.026

0.06

− 0.08

0.14

0.590

Gender

0.096

0.13

− 0.004

0.51

0.053

0.253
***

0.10

0.33

0.72

< 0.001

0.185
***

0.21

0.37

10.21

< 0.001

Model 1: R2 = 0.04, adjusted R2 = 0.03, F(5, 428) = 3.78, p = 0.002; Model 2: R2 = 0.11, adjusted R2 = 0.10, F(5, 424) = 10.55, p < 0.001; Model
3: R2 = 0.03, adjusted R2 = 0.02, F(5, 425) = 2.83, p = 0.016; β Standardized regression coefficient, SE Standard error, CI Confidence interval,
LL Lower limit, UL Upper limit, p = p-value. *p < 0.05, ** p < 0.01, *** p ≤ 0.001

Table 5  Linear regression coefficients for the association between medical avoidance types and participant sexual orientation
Model 1: General Avoidance
β

SE

LL
Sexual Orientation
Covariates
Age
Education
Income
Gender

p

95% CI

Model 2: Discrimination Avoidance

Model 3: COVID Avoidance

β

β

SE

UL

p

95% CI
LL

SE

UL

p

95% CI
LL

UL

− 0.055 0.13 − 0.41 0.11

0.249 0.292 ***

0.09 0.23

0.60

< 0.001 − 0.039

0.21 − 0.59 0.24

0.417

− 0.088
− 0.091
− 0.043
0.080

0.110
0.094
0.359
0.100

0.01
0.03
0.02
0.09

0.002
0.12
− 0.03
0.60

0.092
0.115
0.001
< 0.001

0.01
0.08
0.05
0.21

0.598
0.725
0.432
< 0.001

0.01
0.05
0.03
0.13

− 0.03
− 0.17
− 0.10
− 0.04

0.003
0.01
0.04
0.47

− 0.085
0.079
− 0.148 **
0.200 ***

− 0.02
− 0.01
− 0.13
0.23

0.029
− 0.019
0.038
0.179 ***

− 0.02
− 0.18
− 0.06
0.35

0.03
0.12
0.15
10.18

Model 1: R2 = 0.04, adjusted R2 = 0.03, F(5, 446) = 3.43, p = 0.005; Model 2: R2 = 0.19, adjusted R2 = 0.18, F(5, 442) = 21.05, p < 0.001; Model
3: R2 = 0.03, adjusted R2 = 0.02, F(5, 443) = 2.73, p = 0.019; β Standardized regression coefficient, SE Standard error, CI Confidence interval,
LL Lower limit, UL Upper limit, p = p-value. *p < .05, ** p < .01, *** p ≤ .001

Table 6  Linear regression coefficients for the association between medical avoidance types and participant BMI
Model 1: General Avoidance
β

BMI
Covariates
Age
Education
Income
Gender

SE

Model 2: Discrimination Avoidance
p

95% CI
LL

UL

β

SE

Model 3: COVID Avoidance
p

95% CI
LL

UL

β

SE

p

95% CI
LL

UL

0.129 *

0.01

0.003

0.05

0.024

0.232 ***

0.01

0.02

0.05

< 0.001

0.051

0.02

− 0.20

0.05

0.378

− 0.083
− 0.095
− 0.072
0.071

0.01
0.06
0.04
0.16

− 0.04
− 0.21
− 0.13
− 0.11

0.01
0.03
0.03
0.50

0.223
0.159
0.202
0.215

− 0.037
0.080
− 0.245 ***
0.256 ***

0.01
0.04
0.03
0.11

− 0.02
− 0.03
− 0.18
0.31

0.01
0.13
− 0.08
0.72

0.558
0.198
< 0.001
< 0.001

0.089
− 0.036
0.023
0.195 **

0.20
0.10
0.07
0.26

− 0.01
− 0.25
− 0.10
0.36

0.06
0.15
0.16
10.37

0.198
0.598
0.684
0.001

Model 1: R2 = 0.04, adjusted R2 = 0.02, F(5, 305) = 3.25, p = 0.007; Model 2: R2 = 0.21, adjusted R2 = .20, F(5, 302) = 15.91, p < 0.001; Model
3: R2 = 0.04, adjusted R2 = .03, F(5, 303) = 2.70, p = 0.021; BMI Body mass index; β Standardized regression coefficient, SE Standard error,
CI Confidence interval, LL = Lower limit, UL Upper limit, p = p-value. *p < 0.05, ** p < 0.01, *** p ≤ 0.001
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general avoidance, or are heavier individuals anticipating
avoiding less?
To examine this, we focused on the groups for whom
there was either a general or discrimination-based avoidance
difference by group: race, sexual orientation, and weight.
However, because these outcome variables are on different
scales, we first rescaled them to the same upper and lower
limits; in this case: 0–10. We also categorized BMI using
CDC cutoff points to aid comparison.
Across all examined social categories, the average level of
avoidance was higher when referring to receiving COVIDrelated care than when thinking about general avoidance or
avoidance due to discrimination. However, the difference
was smaller for individuals from the minoritized groups
(race, sexual orientation, and weight, respectively) than
majoritized individuals. On the rescaled variables, we see
differences in avoidance for heavier-weight individuals
when comparing their COVID-related avoidance to their
general medical avoidance. So-called “healthy weight”
individuals (BMI of 18.5–25) reported avoidance of general medical care at a rescaled average of 3.88 points, but
their average COVID-related avoidance score was 4.79
points; a difference of 0.91. In contrast, participants with
a BMI in the “obese” range only showed difference of 0.13
points (Mgeneral = 4.73 to MCOVID = 4.86). However, a univariate ANOVA showed no significant differences by weight
category, F (3, 311) = 1.074, p = 0.360. White individuals’
endorsement of COVID-related avoidance was 2.34 points
higher than their discrimination-based avoidance endorsement (from Mdiscrimination = 2.28 to MCOVID = 4.62), whereas
non-White individuals only showed a 1.17 point difference
(Mdiscrimination = 3.26 to MCOVID = 4.43). Similarly, heterosexual (or straight) individuals scored 3.35 points higher
on COVID avoidance relative to discrimination avoidance
(Mdiscrimination = 1.17 to MCOVID = 4.52), while non-heterosexual individuals showed only a 1.1 point difference
(Mdiscrimination = 3.45 to MCOVID = 4.55). Independent t-tests
examining the contrast between COVID- and discrimination-related avoidance confirmed both of these differences
to be significant: racial difference, t(456) = 2.761, p = 0.006;
sexual orientation difference t(460) = 5.194, p < 0.001.
Across these three groups (race, sexual orientation, and
weight) we see an increase in avoidance to treat COVIDrelated symptoms, but the change is less dramatic in minoritized individuals.

Discussion
The COVID-19 pandemic has created an array of challenges
for the healthcare system and those needing healthcare services. Many people have utilized medical treatment less
often due to widespread information about COVID-related
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barriers to care (e.g., resources averted to COVID, no vacant
hospital beds; Haut et al., 2020; Moghadas et al., 2020).
However, others may avoid seeking care because of their
own personal tendency to avoid medical care, or because
they are concerned about experiencing discrimination in
the healthcare setting (Patel et al., 2020). Communities who
have been historically marginalized and treated less compassionately in the medical context at large report avoiding healthcare and cite fear of discrimination as a reason
for that avoidance (D’Anna et al., 2018; Mensinger et al.,
2018). Further, the widespread personal and systemic stress
caused by the COVID-19 pandemic may exacerbate the
desire to avoid formal healthcare due to the disproportionate amount of minoritized people receiving no or low-quality
care and subsequently higher mortality rates compared to
majoritized people. Studies conducted during the first year
of the pandemic reported that people who identified as Black
race in particular were associated with a greater likelihood
of contracting COVID-19, and higher risk of hospitalization (Munoz-Price et al., 2020; Rogers et al., 2020). Newer
data published by the Centers for Disease Control in March
2022 show that these disparities have only persisted. Compared to non-Hispanic White people, individuals identifying as Black/African American, Hispanic/Latino, or Native
American were between 2.3 and 3.1 times more likely to be
hospitalized for COVID-19, and between 1.7 and 2.1 times
more likely to die from COVID-related complications (CDC,
2022). The daily awareness of subpar COVID-19 healthcare
and treatment for people in one’s community may further
internalize the desire to avoid healthcare.
In the current study, we examined COVID-19-related
medical avoidance in association with race, ethnicity, sexual
orientation, and BMI in a large sample of 471 adults, collected during the 2020 COVID-19 pandemic in the United
States. We also provided a comparative context, examining both general medical avoidance (i.e., avoidance of care
despite suspected need of care) and discrimination-based
medical avoidance (i.e., avoidance of care related to receiving differential, poorer treatment based on one’s identity)
in these subgroups of participants. Our results showed that
general medical avoidance was nuanced, with higher BMI
related to more avoidance, but a non-White racial identity
was related to less avoidance when controlling for other sociodemographic factors. However, for discrimination-based
medical avoidance, participants with a higher BMI, who
were not White, and/or who were not heterosexual, reported
more avoidance. Latinx/e vs. non-Latinx/e identity was not
associated with healthcare avoidance in general or due to
discriminatory concerns.
Regarding race, these results are contrary to prior literature on medical avoidance and racial identity, which show
greater avoidance among non-White patients, compared to
White patients (Carethers et al., 2020; Czeisler et al., 2020).
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Our results did not replicate that pattern of findings, and in
fact found the opposite effect, with White participants being
more generally avoidant of healthcare when controlling for
gender, education, and income. However, our measure of
discrimination-based medical avoidance did show racial
differences, with White participants having lower avoidance scores than non-White participants. Taken together,
this speaks to the need for consideration of the assessments
used in future research on racial disparities in healthcare
seeking and resource utilization. Although a sizeable literature documents more medical avoidance on behalf of
people of color (e.g., Fiscella & Sanders, 2016), parsing
discrimination-based avoidance from other psychological
and structural barriers may provide a more nuanced, and
ultimately more accurate, understanding of health-seeking
behaviors. Additionally, these results provide further evidence for discrimination as a major contributing factor to
healthcare avoidance.
Non-heterosexual, compared to heterosexual, sexual orientation was associated with greater medical avoidance due
to discrimination, but not general or COVID-19 concerns.
This finding aligns with extant literature that characterizes
non-heterosexual adults’ hesitance to disclose their sexual
orientation to providers and seek care due to concerns about
negative reactions, bias, prejudice, and poor treatment (Bjarnadottir et al., 2017; Ogden et al., 2020; Rossman et al.,
2017). The lack of differences in general and COVID-19-related medical avoidance based on sexual orientation in our
sample suggest that concerns about discrimination may drive
disparities in engagement with medical services. Additionally, differences in medical avoidance based on sexual orientation for viruses where sexual orientation is relevant to risk
(e.g., HIV, AIDS; Price et al., 2020) may not be generalizable to avoidance of COVID-19 treatment.
BMI was related to medical avoidance in general and
medical avoidance due to discrimination concerns. That
BMI was the sole identity marker that emerged as significant
for both forms of medical avoidance suggests that these concerns are especially salient for larger-bodied people. Empirical literature on weight stigma has documented the vast
impacts that societal views about body size can have on wellbeing, including increased depression and anxiety, social
withdrawal, and harmful body-modifying behaviors (e.g.,
extreme dieting) that have long-term physical consequences
(for reviews, see Pearl & Puhl, 2018; Puhl & Heuer, 2009).
Weight stigma further harms well-being through providers’
internalized views, which affect their prescribed treatment
(Phelan et al., 2014) and, as our results show, perpetuate
personal health issues by creating an aversive environment to
those needing healthcare services. The finding of more general medical avoidance for people with larger BMIs is likely
another downstream effect of weight stigma. The combined
psychological and physical impacts of discrimination, such
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as anxiety and participation in health-debilitating behaviors
(Hunger et al., 2015; Tomiyama, 2014), may underlie the
general tendency to not want one’s body examined.
Of particular note, our results showed that none of our
targeted identities related to COVID-19 medical avoidance.
Participants’ race, ethnicity, sexual orientation, and BMI
were unrelated to their likelihood of seeking healthcare
for COVID-19. These results hold when controlling for the
effects of participant age, gender, income, and education
level. In contrast with healthcare intended for other medical issues, it appears that this novel coronavirus motivates
healthcare-seeking behavior similarly among marginalized
and majoritized groups. Our results appear to contrast with
recent work on healthcare seeking behaviors among marginalized groups during the COVID-19 pandemic. This
work suggests that Black adults and, in some cases, Hispanic adults tend to report higher rates of medical avoidance
(Czeisler et al, 2020; Gonzalez et al., 2021) when compared
to their White counterparts. Additionally, Gonzalez et al.,
(2021) found that adults with high BMI scores also tended
to report delaying or avoiding care at a high rate. However,
these studies focused on broader healthcare avoidance, rather
than avoidance of COVID-19 healthcare.
The airborne nature and easy transmission of COVID19 have made contracting the virus somewhat biologically
indiscriminate. However, the quality of recovery and the
likelihood of exposure differs by socioeconomic status and
diagnosis of comorbid conditions (Hawkins et al., 2020;
Jackson et al., 2021; Jaljaa et al., 2022; SeyedAlinaghi et al.,
2021). Thus, the idea of the type of person who contracts or
spreads COVID-19 may not be formed around any specific
appearance or attribute—with some exceptions. Studies have
documented COVID-19-based stigma toward people who
currently are or have previously been infected (e.g., Abuhammad et al., 2021; Lohiniva et al., 2021), and especially
toward healthcare personnel treating patients with COVID19 (Bagcchi, 2020; Grover et al., 2020; Gutierrez et al.,
2022; Khan et al., 2021; Ramaci et al., 2020). However, at
this time, the only known demographic characteristic that
produces COVID-19 stigma in the United States is Asian
race (Gutierrez et al., 2022).
This pandemic serves as an unanticipated public health
phenomenon that should be noted by researchers and interventionists: messaging around illnesses is critically important for motivating health promotion for all groups but especially marginalized groups. Framing messaging so that it
reflects a public health issue at-large rather than emphasizing specific groups (e.g., as with HIV and men who have
sex with men) may reduce barriers to healthcare in this particular context. Gronholms et al.’s (2021) comprehensive
analysis of previous stigma-reduction interventions posed
similar recommendations for COVID-19 interventions.
First, campaigns and interventions should be intentional in
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not attaching target identities (i.e., locations or ethnicities)
to public health messages. Second, universal public health
strategies, compared to targeted messages, can reduce stigma
and combat blame placed on specific communities (Gronholm et al., 2021). We caution against recommending a onesize-fits-all messaging approach with any healthcare issue
but put forward our results as pieces to consider in developing new approaches to public health promotion.

Limitations
While this study provides important and novel findings
regarding medical avoidance and stigma in the COVID-19
context, it also has several limitations. Due to the small sample sizes of distinct racial groups, all non-White participants
were analyzed in aggregate in order to achieve sufficient
power for comparative analyses. This dichotomous variable
approach limited the amount of nuance regarding the associations between race and medical avoidance, and future
research would benefit from recruiting larger samples from
non-White racial groups.
Relatedly, sample size limitations also limited the application of an intersectional framework for this study. In the
present study, we took a single-axis approach to power and
oppression in which we only explored race, ethnicity, sexual
identity, and body size as separate predictors rather than
considering their intersections. For example, no differences
were found between Latinx/e and non-Latinx/e participants
despite prior research that suggests differences in medical
avoidance between these groups. This unexpected finding
may in part be due to our decision to evaluate marginalized identities separately instead of taking an intersectional
approach (e.g., Latinx/e and non-Latinx/e participants with
higher BMIs) based on limitations in sample size and statistical power to detect effects. These limitations stress the
importance of recruiting sufficiently large sample sizes of
groups with intersecting facets of their marginalized identities. Additionally, in the present analysis we did not examine
the role of socioeconomic status, immigration status, gender identity, age, ability, or chronic illness as other potential
sources of health care avoidance that should be examined
further in future studies.

Conclusion
This study supports and extends some of the existing literature regarding differences in medical avoidance behaviors
among people with multiple marginalized identities. Our
findings also contribute to literatures on medical avoidance
in general, and discrimination-based medical avoidance
more specifically, among people facing stigma in healthcare
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settings. These findings point to the need for interventions
in both healthcare messaging and provider-patient communication to reduce stigmas surrounding race, ethnicity,
and weight to enable more people to seek care without fear
of discrimination. In addition, this study presents notable
findings regarding medical avoidance and the effect that
COVID-19 may have regarding the observed difference in
medical avoidance disparities between traditionally marginalized and non-marginalized groups. While marginalized
people may be just as likely to seek healthcare when they
are facing potentially fatal illness, it is crucial to continue
efforts to make healthcare environments safer for marginalized individuals to seek all types of care, including prevention and treatment.
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